University of Guadalajara
Also known as: Adolfo Daniel Rodriguez-Carrizalez | Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara | Doctorado en Farmacologia de la Universidad de Guadalajara | full time staff member at the Division of Pediatrics of the New Civil Hospital of Guadalajara | Head, Molecular Biology and Genomics Department, University of Guadalajara | Hospital Civil de Guadalajara | Hospitales Civiles de Guadalajara, Mexico | Institute of Experimental and Clinical Therapeutics | Institute of Experimental and Clinical Therapeutics (INTEC), CUCS | Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara | Instituto de terapeutica experimental y clínica | Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara | Instituto de terapéutica experimental y clínica (INTEC) | Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara | New Civil Hospital of Guadalajara | PhD. Teresa Arcelia Garcia Cobian | Ramón Óscar González-Ramella, Ph.D | Royal University of Guadalajara | Universidad de Guadalajara | Universidad De Guadalajara (UDG) | University Guadalajara | University of Guadalajara
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2003Last known activity
Sep 15, 2025
Timeline
1920s
- Jan 1, 1925
University of Guadalajara— Founded
Drugs by trial phase (122 distinct, 101 trials)
Phase 4 (27 own, 0 via acquisition)
Phase 3 (35 own, 0 via acquisition)
Phase 2 (43 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (16 own, 0 via acquisition)
Indications
Studied for
- Acne Vulgaris
- Acquired Immunodeficiency Syndrome
- Acute Kidney Injury
- Arthritis
- Arthritis, Rheumatoid
- Body Weight
- Body Weight Changes
- Carcinoma in Situ
- Cardio-Renal Syndrome
- Carpal Tunnel Syndrome
- Cerebral Palsy
- Constipation
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Foot
- Diabetic Neuropathies
- Diabetic Retinopathy
- Dyslipidemias
- Fibrosis
- Foot Ulcer
- Glucose Intolerance
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- HIV Infections
- Hyperglycemia
- Hyperplasia
- Hypersensitivity
- Hypertension
- Hypothyroidism
- Immunologic Deficiency Syndromes
- Inflammation
- Insulin Resistance
- Kidney Diseases
- Leukemia
- Leukemia, Lymphoid
- Metabolic Syndrome
- Neoplasm Metastasis
- Neoplasms
- Obesity
- Osteoporosis
- Overweight
- Paralysis
- Polyneuropathies
- Postoperative Pain
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Prediabetic State
- Pre-Eclampsia
- Prehypertension
- Renal Insufficiency, Chronic
- Retinal Diseases
- Shock
- Shock, Septic
- Syndrome
- Ulcer
- Wounds and Injuries
Recent trials (50)
- NCT07056712Lead sponsorN/ASep 15, 2025
- NCT07056712Sponsor investigatorN/ASep 15, 2025
- NCT07056712OfficialN/ASep 15, 2025
- NCT07060222Lead sponsorPhase 4Jul 20, 2025
- NCT07060222Sponsor investigatorPhase 4Jul 20, 2025
- NCT06915701Lead sponsorPhase 2/Phase 3Apr 28, 2025
- NCT06915701OfficialPhase 2/Phase 3Apr 28, 2025
- NCT06829186CollaboratorPhase 2Mar 15, 2025
- NCT06829186Lead sponsorPhase 2Mar 15, 2025
- NCT06829186Sponsor investigatorPhase 2Mar 15, 2025
- NCT06333834Sponsor investigatorPhase 2/Phase 3Jun 15, 2024
- NCT06333834Lead sponsorPhase 2/Phase 3Jun 15, 2024
- NCT06061783Overall official - principal investigatorN/ANov 30, 2023
- NCT06061783Reponsible party - principal investigatorN/ANov 30, 2023
- NCT06061783Lead sponsorN/ANov 30, 2023
Details
- Founded
- Guadalajara, MX Jan 1, 1925
- Last known activity
- Sep 15, 2025